FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Pfizer Fentanyl Citrate Inj Recall

Fentanyl Citrate Inj

Pfizer Inc. · New York, NY

Risk level
Class II
Reported by FDA
Aug 12, 2020
Recall ID
D-1446-2020
Check your lot numberHow we source this data

Summary

Pfizer recalled Fentanyl Citrate Inj starting Jul 20, 2020. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1446-2020 on Aug 12, 2020. Reason: Lack of Assurance of Sterility; potential loose metal overseal crimp defects. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility; potential loose metal overseal crimp defects.

Product description

Fentanyl Citrate Inj., USP 100 mcg Fentanyl/2 mL (50 mcg/mL) 2 mL Single-dose Fliptop Vials, Rx only, Distributed by Hospira, Inc. Lake Forest, IL 60045 USA NDC 0409-9094-12

Lot numbers, UPCs & expiration codes

Lots: Tray lot: 13405DK Vial lot: 13-405 DK Exp. 1JUL2021, Tray lot: 17096DK Vial lot: 17-096-DK Exp. 1NOV2021

Where it was sold

United States including Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1446-2020
Classification
Class II
Status
Terminated
Recall initiated
Jul 20, 2020
FDA report date
Aug 12, 2020
Quantity
19,144 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Pfizer Inc.

Original FDA data

Every field from FDA enforcement report D-1446-2020, exactly as published.

Show all FDA fields
City
New York
State
NY
Status
Terminated
Country
United States
Event ID
86074
Address
235 E 42nd St
Code information
Lots: Tray lot: 13405DK Vial lot: 13-405 DK Exp. 1JUL2021, Tray lot: 17096DK Vial lot: 17-096-DK Exp. 1NOV2021
Postal code
10017-5703
Report date
Aug 12, 2020
Product type
Drugs
Recall number
D-1446-2020
Classification
Class II
Recalling firm
Pfizer Inc.
Product quantity
19,144 vials
Termination date
Dec 8, 2022
Reason for recall
Lack of Assurance of Sterility; potential loose metal overseal crimp defects.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Fentanyl Citrate Inj., USP 100 mcg Fentanyl/2 mL (50 mcg/mL) 2 mL Single-dose Fliptop Vials, Rx only, Distributed by Hospira, Inc. Lake Forest, IL 60045 USA NDC 0409-9094-12
Distribution pattern
United States including Puerto Rico
Recall initiation date
Jul 20, 2020
Initial firm notification
Letter
Center classification date
Aug 4, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1446-2020, published Aug 12, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls